Cost- Effectiveness Study of Brief Interventions for Mood and Anxiety Disorders
K&K
A Efficacy and Cost-effectiveness Study of a Brief Interventions for Mood and Anxiety Disorders: Brief Intake, Treatment and Routine Outcome Monitoring (ROM)
1 other identifier
interventional
182
1 country
1
Brief Summary
This study compares both clinical effectiveness and cost-effectiveness of a brief, intensified therapy and diagnostic method for patients with mood and/or anxiety disorders with Treatment As Usual (TAU) at five outpatient Mental Healthcare Centers in the Netherlands.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2010
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2010
CompletedFirst Submitted
Initial submission to the registry
September 8, 2011
CompletedFirst Posted
Study publicly available on registry
July 18, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJune 11, 2013
June 1, 2013
2.8 years
September 8, 2011
June 10, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Effectiveness of the intervention
Effectiveness of the intervention is investigated by the main questionnaires: Web Screening Questionnaire (WSQ) and Brief Symptom Inventory (BSI) as conducted by ROM
approximately 3 years (start: march 2010).
Secondary Outcomes (1)
Cost-effectiveness intervention
approximately 3 years (start: march 2010).
Study Arms (2)
Cognitive behavioral treatment/farmacotherapy intervention
EXPERIMENTALBrief intervention; intake, cognitive behavioral treatment/farmacotherapy (SSRI) and ROM
Treatment As Usual
OTHERControl group, TAU
Interventions
Brief cognitive behavioral intervention/farmacotherapy; intake, treatment and ROM
Eligibility Criteria
You may qualify if:
- Male of female adolescents
- Adolescents aged between 18 to 65 year
- Adolescents main complaint: Mild to moderate anxiety and/or mood disorders with or without psychiatric and/or somatic co-morbidity
- Adolescents with proper understanding of the Dutch language.
You may not qualify if:
- Adolescents with current psychotic or bipolar traits,
- Adolescents with homicidal or suicidal risk
- Adolescents with severe social disfunctioning
- No proper understanding of the Dutch language
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Leiden University Medical Centerlead
- GGZ Rivierduinencollaborator
Study Sites (1)
Rivierduinen
South Holland, Netherlands
Related Publications (1)
Meuldijk D, Carlier IV, van Vliet IM, van Veen T, Wolterbeek R, van Hemert AM, Zitman FG. The clinical effectiveness of concise cognitive behavioral therapy with or without pharmacotherapy for depressive and anxiety disorders; a pragmatic randomized controlled equivalence trial in clinical practice. Contemp Clin Trials. 2016 Mar;47:131-8. doi: 10.1016/j.cct.2015.12.021. Epub 2016 Jan 5.
PMID: 26762883DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PhD Student
Study Record Dates
First Submitted
September 8, 2011
First Posted
July 18, 2012
Study Start
March 1, 2010
Primary Completion
December 1, 2012
Study Completion
December 1, 2012
Last Updated
June 11, 2013
Record last verified: 2013-06